The Aftercare of the Patient with the Neuroleptic Malignant Syndrome
- 1 March 1985
- journal article
- case report
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 146 (3) , 317-318
- https://doi.org/10.1192/bjp.146.3.317
Abstract
Summary: The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to neuroleptic drugs, made up of hyperthermia, muscular rigidity, disturbance of level of consciousness and autonomic dysfunction. It is potentially lethal and should be kept in mind whilst using anti-psychotic drugs; as most patients treated by them require further anti-psychotic treatment, the clinician faces the problem of treating those patients after a NMS episode, yet reports in the literature have generally neglected the problem of late management. A patient suffering from a psychosis and NMS is presented, and a rationale for management offered.Keywords
This publication has 11 references indexed in Scilit:
- Neuroleptic malignant syndrome.BMJ, 1984
- Neuroleptic malignant syndrome.BMJ, 1983
- TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENEThe Lancet, 1982
- The Neuroleptic Malignant SyndromeArchives of internal medicine (1960), 1982
- Neuroleptic malignant syndromeNeurology, 1981
- Malignant neuroleptic syndrome: An atypical casePsychosomatics, 1979
- Rigidity, hyperpyrexia and coma following fluphenazine enanthatePsychopharmacology, 1973
- Parenteral long-acting phenothiazines.BMJ, 1972
- Side effects of parenteral long-acting phenothiazines.BMJ, 1972